The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Nov 2022 to Jan 2023. No more shares have been issued.
I see no reason why the sp could not re-rate to around 50p a share in view of the recent fantastic news.
All IMHO.
Please explain?
LOL! Up 29% now.
So, did you have a short position?
Did you close it today?
Pray tell.
Rolling in, including the one today with Astrazeneca for over half a million £.
Shorters want holders to sell.
Mr Newland in the interview said they are talking to "11 other possible customers, 6 are "household" names"..........
Bound to be additional contracts from Eisai and Astrazeneca too IMHO.........
8 months to land more contracts. Cash call may NOT be needed................
All IMHO.
Up 25% now.
Good luck.
Up 21%. Ticked up again.
Bantham. You only seem to have negative thoughts! The sp is telling us things are picking up BIGTIME. The sp was a tad below 10p last November. It's now 16.75p. More than 50% more. The contracts have only just started to arrive. LOADS to come IMHO.
All IMHO.
Up 20% now.
Just ticked up.
Wow. Don't see that very often!
Bantham. That statement is ridiculous. For example. Angle are looking for a Pharma partner to join them and Bioview to market the HER2 system Bioview and Angle have spent just over a year developing. An up front payment to become that partner could be in the milions. Just one example. We know they talk to Eisai and Astrazeneca already......
You are so quick to look on the bad side!
All IMHO.
Landing a half million £ contract with Astrazeneca might be better appreciated by the yanks!
Bantham.
It's 4th May 2024. Angle cash runway WAS until 1st quarter 2025. It is possible a cash raise won't be necessary. Mr Newland in the interview said they are talking to "11 other possible customers, 6 are "household" names"..........
Bound to be additional contracts from Eisai and Astrazeneca too IMHO.........
8 months to land more contracts. It's easily doable now.
All IMHO.
After the FIRST Astrazeneca contract on 24th April.....
THIS TIME I THINK 20P PLUS.
USA interest..........
aLL imho!!!
Will top 20p a share TODAY IMHO!!!!!!!!!!!!! Listen to this!!!!:-
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
holy *****!!!!
"astra have 460 active cance trials with 140,000 patients involved.".
halo effect.... knock on impact. pipeline of 11 other possible customers, 6 are "household" names!!!!!!!>>
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
Parsortix has FDA approval for medical use in the USA for Breast cancer. There is a massive world wide market for this alone. Massive.
Even more massive IMHO it can be used for ***ANY cancer during a cancer drug trial***. There is £ millions to be made from Parsortix being used during drug trials. The RNS of 4th Jan IS THE MOST SIGNIFICANT ANNOUNEMENT AGL HAVE MADE EVER IMHO. It shows with the dual CtDNA and CTC analysis a cancer that has matastacised can be MONITORED to find out HOW THE NEW DRUG IS PERFORMING !!!!!!!!! Before. DURING and AFTER treatment!!!!
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
All IMHO.
Sp peaked around 13:45 @ 17p bid After the FIRST Astrazeneca contract on 24th April.....
Hello.
Ask 16p now.
After the FIRST Astrazeneca contract on 24th April.....
USA interest presumably..........
Angle now have one contract with Eisai Inc. of Japan (top 100 Company in Japan) and two contracts with Astrazeneca (Top 100 UK Plc). Doing business with these MASSIVE Companies is only going to lead to more and more contracts with them.......... AND other Plc's IN THE WORLD. The World is a big place and there are thousands of other Companies out that can obviously contact Angle via their WEB site and go from there. The "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample" is going to be transformational for Angle, and they have not YET announced the first customer following the RNS of 4th Jan:-
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
Can't wait!! They are going to be turning customers away IMHO.
All IMHO.